Phase III trial investigating the efficacy and safety of sildenafil/testosterone [Lybrido] for the treatment of hypoactive sexual desire disorder

Trial Profile

Phase III trial investigating the efficacy and safety of sildenafil/testosterone [Lybrido] for the treatment of hypoactive sexual desire disorder

Not yet recruiting
Phase of Trial: Phase III

Latest Information Update: 01 May 2015

At a glance

  • Drugs Sildenafil/testosterone (Primary)
  • Indications Female sexual dysfunction
  • Focus Therapeutic Use
  • Most Recent Events

    • 01 May 2015 Emotional Brain has discussed their Phase III program with the US FDA under their SPA procedure and this trial is expected to be initiated in the third or fourth quarter of 2015, according to an Emotional Brain media release.
    • 17 Apr 2015 This trial is expected to be initiated in 2015, according to an Emotional Brain media release.
    • 11 Mar 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top